Minocycline-induced cutaneous pigmentation

Journal of Cutaneous Medicine and Surgery

Volumn 3, Issue 2, 1998, Pages 105-108

  Wasel, Norman R ^a   Schloss, Eric H ^a   Lin, Andrew N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; TETRACYCLINE DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FOREARM; HUMAN; HYPERPIGMENTATION; LEG; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0031768547     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549800300211     Document Type: Article

References (47)

1. Tilley BC, Alarcon GS, Heyse SP, et al. Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial. MIRA Group. Ann Intern Med 1995; 122:81-89.
2. Held JL, Silvers DN, Grossman ME. Hyperpigmentation of the lower extremities associated with porphyria cutanea tarda. Arch Dermatol 1989; 125:297-298.
3. Granstein RD, Sober AJ. Drug- and heavy metal-induced hyperpigmentation. J Am Acad Dermatol 1981; 5:1-18.
4. Stanove A. Pigmentation due to phenothiazines in high and prolonged dosage. JAMA 1965; 191:263-268.
5. Levantine A, Almeyda J. Drug-induced changes in pigmentation. Br J Dermatol 1973; 89:105-112.
6. Tuffanelli D, Abraham RK, Dubois EI. Pigmentation from antimalarial therapy: its possible relation to the ocular lesions. Arch Dermatol 1963; 88:419-426.
7. Klein AD, Pardo RJ, Gould E, et al. Blue-gray discoloration of the face. Arch Dermatol 1989; 125:417.
8. Alinovi A, Reverberi C, Melissari M, et al. Cutaneous hyperpigmentation induced by amiodarone hydrochloride. J Am Acad Dermatol 1985; 12:563-566.
9. Mahler R, Sissons W, Watters K. Pigmentation induced by quinidine therapy. Arch Dermatol 1986; 122:1062-1064.
10. Hashimoto K, Joselow SA, Tye MJ. Imipramine hyperpigmentation: a slate-gray discoloration caused by long-term imipramine administration. J Am Acad Dermatol 1991; 25:357-361.
11. Steele TE, Ashby J. Desipramine-related slate-gray skin pigmentation. J Clin Psychopharmacol 1993; 13:76-77.
12. Hoshaw RA, Zimmerman KG, Menter A. Ochronosis-like pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol 1985; 121:105-108.
13. Litt JZ. Drug eruption reference manual, 1998. New York: Parthenon Publishing, 1998:157-158, 429.
14. Bork K. Cutaneous side effects of drugs. Philadelphia, PA: WB Saunders, 1988:201.
15. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline: report of 13 patients and review of the literature. Arch Dermatol 1996; 132:934-939.
16. Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in treatment of acne. Br J Dermatol 1996; 134:693-695.
17. Thibault M-J, Billick RC, Srolovitz H. Minocycline-induced Sweet's syndrome. J Am Acad Dermatol 1992; 27:801-804.
18. Siller GM, Tod MA, Savage NW. Minocycline-induced oral pigmentation. J Am Acad Dermatol 1994; 30:350-354.
19. Katz J, Barak S, Shemer J, et al. Black tongue associated with minocycline therapy. Arch Dermatol 1995; 131:620-621.
20. Parniex-Spake A, Bastuji-Garin S, Lobut J-B, et al. Minocycline as possible cause of severe and protracted hypersensitivity drug reaction. Arch Dermatol 1995; 131:490-491.
21. Karofsky PS. Minocycline-induced rash in an 18-year-old patient. Arch Pediatr Adolesc Med 1995; 149:217-218.
22. Bridges AJ, Graziano FM, Calhoun W, et al. Hyperpigmentation, neutrophilic alveolitis, and erythema nodosum resulting from minocycline. J Am Acad Dermatol 1990; 22:959-962.
23. Chu P, Van SL, Yen TSB, et al. Minocycline hyperpigmentation localized to the lips: an unusual fixed drug eruption? J Am Acad Dermarol 1994; 30:802-803.
24. Dwyer CM, Cuddihy AM, Kerr REI, et al. Skin pigmentation due to minocycline treatment of facial dermatoses. Br J Dermatol 1993; 129:158-162.
25. Argenyi ZB, Finelli L, Bergfeld WF, et al. Minocycline-related cutaneous hyperpigmentation as demonśtrated by light microscopy and x-ray energy spectroscopy. J Cutan Pathol 1987; 14:176.
26. Basler RSW. Minocycline-related hyperpigmentation. Arch Dermatol 1985; 121:606-608.
27. Fenske N, Millns JL, Greer KE. Minocycline-induced pigmentation at sites of cutaneous inflammation. JAMA 1980; 244: 1103-1106.
28. Basler RSW, Kohnen PW. Localized hemosiderosis as a sequelae of acne. Arch Dermatol 1978; 114:1695-1697.
29. Lever WE Histopathology of the skin. Lippincott, 1996:294.
30. Altman DA, Fivenson DP, Lee MW. Minocycline hyperpigmentation: a model for in situ phagocytic activity of factor XIIIa-positive dermal dendrocytes. J Cutan Pathol 1992; 19:340.
31. Ridgway HA, Sonnex TS, Kennedy CTC, et al. Hyperpigmentation associated with oral minocycline. Br J Dermatol 1982; 107:95-102.
32. Sato S, Murphy GF, Bernhard JD, et al. Ultrastructural and x-ray microanalytical observations of minocycline-related hyperpigmentation of the skin. J Invest Dermatol 1981; 77:264-271.
33. Pepine M, Flowers FP, Ramos-Caro FA. Extensive cutaneous hyperpigmentation caused by minocycline. J Am Acad Dermatol 1993; 28:292-295.
34. Caro I. Discoloration of the teeth related to minocycline therapy for acne. J Am Acad Dermatol 1980; 3:317-318.
35. Basler RSW. Minocycline therapy for acne. Arch Dermatol 1979; 115:1391-1392.
36. Wolfe ID, Reichmister J. Minocycline hyperpigmentation: skin, tooth, nail, and bone involvement. Cutis 1984; 33:457-458.
37. White SW, Besanceney C. Systemic pigmentation from tetracycline and minocycline therapy. Arch Dermatol 1983; 119:1-2.
38. Eisen D. Minocycline-induced oral hyperpigmentation. Lancet 1997; 349:400.
39. Basler RSW, Goetz CS. Synergism of minocycline and amitriptyline in cutaneous hyperpigmentation. J Am Acad Dermatol 1985; 12:577.
40. Angeloni VL, Salasche SJ, Ortiz R. Nail, skin, and scierai pigmentation induced by minocycline. Cutis 1987; 40:229-233.
41. Gordon G, Sparano BM, Iatropoulos MJ. Hyperpigmentation of the skin associated with minocycline therapy. Arch Dermatol 1985; 121:618-623.
42. Simons JL, Morales A. Minocycline and generalized cutaneous pigmentation. J Am Acad Dermatol 1980; 3:244-247.
43. McGrae JD, Zelickson AS. Skin pigmentation secondary to minocycline therapy. Arch Dermatol 1980; 116:1262-1265.
44. Tsao H, Busam K, Barnhill RL, et al. Treatment of mino-cycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol 1996; 132:1250-1251.
45. Knoell KA, Milgraum SS, Kutenplon M. Q-switched ruby laser treatment of minocycline-induced cutaneous hyperpigmentation. Arch Dermatol 1996; 132:1251-1253.
46. Wilde JL, English JC III, Finley EM. Minocycline-induced hyperpigmentation: treatment with the neodymium: YAG laser. Arch Dermatol 1997; 133:1344-1346.
47. Greve B, Schonermark MP, Raulin C. Minocycline-induced hyperpigmentation: treatment with the Q-switched Nd:YAG laser. Lasers Surg Med 1998; 22:223-227.